Help your patients stay fully engaged in daily activities and enjoy their quality of life with science-based compression therapy and skin integrity solutions.
Lymphedema and chronic edema are conditions characterized by swelling due to the build-up of lymph fluid in the tissues just under the skin. The swelling is most often seen in arms or legs, but not exclusively. It often causes pain and discomfort, affecting mobility and appearance, and can negatively impact a patient’s mental health, further affecting their quality of life.
Our goal is to apply science to alleviate problems associated with abnormal swelling and enable patients to lead more active lives. Compression therapy is widely accepted as an effective component of lymphedema and chronic edema treatment.
Complex decongestive therapy (CDT) involves a combination of treatment approaches for managing edema and lymphedema, including skin care, manual lymphatic drainage, compression therapy and exercise. The main goals of the therapy are listed below.
Skin care is essential to patient vitality and critical for good health. Good skin care can help prevent deterioration and ulceration, which is why it’s important to encourage patients to take an active role in their own care.
As part of a lymphedema treatment regimen to reduce swelling, this gentle, non-invasive manual massaging technique encourages the natural drainage of the lymph.¹,²
Compression bandaging is a cornerstone of CDT. It is essential to reduce volume to enable the patient to move into compression hosiery. Ideal compression incorporates inelastic and elastic components, allows for full functionality and movement, is easy to apply and adapt to a range of limb sizes and shapes, is durable and non-allergenic, and is comfortable for the patient.
Exercise is vital for overall and lymphatic health as well as mental well-being. The type of exercises you encourage your patients to perform depends on their current physical activity level, age, personality, and their edema. Patients should exercise while wearing compression to stimulate the lymphatic system and increase venous return.
The 3M™ Coban™ 2 Two-Layer Compression System provides effective compression therapy, which has been shown to contribute to effective venous leg ulcer (VLU) management through edema reduction, decreased pain and improvement in a patient’s daily activities.³,⁴
3M™ Coban™ 2 Two-Layer Compression System
The Coban 2 Compression System is easy to apply and remove, and provides effective compression therapy. Effective compression has shown to reduce edema, decrease pain, and improve a patient’s daily activities. For patients with ankle brachial pressure index (ABPI) greater than or equal to 0.8.
3M™ Coban™ 2 Lite Two-Layer Compression System
The Coban 2 Lite Compression System is engineered to stay in place and deliver comfortable, effective, modified light therapeutic compression (25-30 mmHg) for patients with ankle brachial pressure index (ABPI) greater than or equal to 0.5. Or for patients that cannot tolerate high compression.
Skin damage such as maceration, erythema are often associated with VLUs. Research supports the routine protection of periwound skin from excess exudate, mechanical trauma, and protection of at-risk, compromised skin as essential steps in VLU wound management and wound bed preparation.⁵
NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for these products and therapies, some of which may be Rx only. Please consult a clinician and product Instruction for Use prior to application.
3M™ Cavilon™ Durable Barrier Cream
This unique, concentrated moisturizing barrier cream formulated with 3M polymers provides durable, long-lasting moisture barrier protection while moisturizing the skin.
3M™ Cavilon™ No Sting Barrier Film
Cavilon No Sting Barrier Film provides a gentler way to protect skin from body fluids, adhesives and friction. The alcohol-free barrier film applies without stinging, and forms a breathable, transparent film for long-lasting protection.
3M™ Cavilon™ Advanced Skin Protectant
Cavilon Advanced Skin Protectant is a highly durable, ultra-thin barrier that attaches to wet, weepy skin⁶ and lasts up to seven days,⁷ creating a protective environment that repels irritants and supports healing.
In a randomized controlled trial, the total cost of care per patient of Coban 2 Compression System’s twice-weekly application was shown to be significantly less than that of the competing brand studied.⁸ In fact, for both arm lymphoedema and leg lymphoedema, the Coban 2 Compression system was shown to cost less than half the nursing time and materials.⁸
Discover online learning that's right for you and deepen your clinical expertise with professional training opportunities and educational resources available on 3M℠ Health Care Academy. 3M webinars and archived events can help keep you up to date with the latest product guidelines and scientifically supported standards of care.
Download the following resource guides to get step-by-step instructions on how to apply compression therapy for a variety of patients using the Coban 2 Two-Layer Compression System.
Explore this full-leg VLU application guide for the Coban 2 Compression System including materials and positioning, compression therapy instructions, and bandage removal.
View Coban 2 Compression System Full Leg Application Guide (PDF, 584 KB)
This VLU application guide is for the Coban 2 Compression System which is for patients with extreme leg contours.
View Coban 2 Compression System Application for a Highly Contoured Leg (PDF, 464 KB)
This VLU application guide is for the Coban 2 Compression System which is ideally suited to help patients with very thin legs and vulnerable bony prominences.
View Coban 2 Compression System Specialty Application for a Thin, Fragile Leg (PDF, 660 KB)
Studies show that less than half of patients wear their compression bandages.¹,² Most often, patients remove their bandages due to pain and/or slippage, which interferes with their daily activities. Patients need to understand the importance of remaining concordant with their compression therapy.
If a patient experiences any of the following signs and symptoms while wearing compression, they should contact their healthcare provider right away:
Once the patient has gone through a reduction phase to reduce swelling, they can move into compression hosiery, including arm sleeves, gloves, trunk compression, stockings, socks, tights or other options depending on the patient’s condition and tolerance.
See how our proprietary combination of products and technology can help you manage wound care the smart way.
Connect with one of our 1,800+ 3M Account Representatives providing support for OR, hospital, patient transitions and post-acute care settings.
Your patients count on you to help them stay out of the hospital and reduce the pain and discomfort caused by DFUs. We offer negative pressure wound therapy (NPWT), advanced wound dressings, and skin integrity solutions to help your patients on their journey to healing.
When pressure injuries can’t be avoided, establish a standard of care that treats the whole patient. 3M can help with solutions to support therapy goals established between you and your patients.
Optimal outcomes start with early treatment and consistent management of traumatic wounds. Together, we can strive to reduce preventable complications, drive toward better outcomes and, ultimately, aspire to restore patients’ lives.
People living with chronic edema and VLUs want to engage fully in everyday activities - without feeling uncomfortable or self-conscious about what’s on their legs and feet. 3M can help manage challenges related to VLUs.
A 3M representative will be in contact with you soon!
An error has occurred while submitting. Please try again.
The 3M Wound Therapy Guide can help assist you in selecting a wound care solution for your patient based on the attributes and treatment objectives you choose. This guide is intended for use by clinicians in the United States for outpatient care.*
You may also view all treatment approaches without specific recommendations.
3M is committed to providing customer service, including product reimbursement education and resources, to clinical providers and healthcare facilities that use qualified 3M products.
We are here to help! Get in touch with our customer support team for advice about our products and how to use them.
View our advanced wound products and NPWT product portfolio and browse our product catalog.
Find Instructions for Use (IFU) to easily access documents for specific 3M Health Care products.
References
1. Moffatt C. International consensus: best practice for the management of lymphoedema. International Consensus: Best Practice for the Management of Lymphoedema. 2006.
2. Glover D. Best Practice for the Management of Lymphoedema - 2nd edition: Compression Therapy: A position document on compression bandaging. International Lymphoedema Framework. 2012
3. Mosti G, Crespi A, Mattaliano V. Comparison Between a New, Two-component Compression System with Zinc Paste Bandages for Leg Ulcers Healing: A Prospective, Multicenter, Randomized, Controlled Trial Monitoring Sub-bandage Pressures. Wounds. 2011; 23(5): 126–134.
4. Moffatt C, Edwards L, Collier M, et al. A randomized controlled 8-week crossover clinical evaluation of the 3M™ Coban™ 2 Layer Compression System versus Profore™ to evaluate product performance in patients with venous leg ulcers. Int Wound J. 2008; 5(2); 267–279
5. Bianchi, J. A. N. I. C. E. (2012). Protecting the integrity of the periwound skin. Wound Essentials, 7(1), 58–64.
6. Brennan, Mary R.; Milne, Catherine T.; Agrell-Kann, Marie; Ekholm, Bruce P. Clinical Evaluation of a Skin Protectant for the Management of Incontinence Associated Dermatitis: An Open-Label, Nonrandomized, Prospective Study. J of Wound, Ostomy & Continence Nursing. 2017. 44(2):172-180.
7. 3M Data on File. EM-05-013924, EM-05-305812.
8. Moffatt C.J., Franks P.J., Hardy D., Lewis M., Feldman J.L. A preliminary randomized controlled study to determine the application frequency of a new lymphoedema bandaging system. British Journal of Dermatology. 2012; 166. 624-632.